• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Administering higher doses of oxytocin does not reduce the use of cesarean sections

Bioengineer by Bioengineer
January 29, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Photo by NU Hospital Group


Delayed labor increases the risk of a caesarean section, even among women who receive oxytocin for augmentation of labour. The rate of caesarean section among first-time mothers is not reduced if the administered dose is doubled either, according to a dissertation from Sahlgrenska Academy at the University of Gothenburg, Sweden.

In her dissertation Lotta Selin, a midwife, studied data on a total of 2,775 births in Sweden. She has focused on the risk and outcomes of delayed labor and how augmentation of labour with oxytocin is managed.

“Other methods of treatment need to be explored more, such as dosages of oxytocin adapted to specific groups of women and methods applied during labou that can stimulate the body’s own production of the oxytocin hormone,” says Lotta Selin.

Delayed labor is common among first-time mothers, which may lead to a caesarean section and a negative birth experience. In the material studied, the rate of emergency cesarean section among first-time mothers with delayed labour was 17.1 percent compared with 2.3 percent for women in the group with a normal progress.

A higher dose of oxytocin, compared with the dose routinely administered today, did not reduce the rate of caesarean section nor did it affect the birth experience. On the other hand, labour was shortened by an average of 23 minutes. No other differences could be demonstrated.

In health care in Sweden, it is common to administer synthetic oxytocin as an intravenous drip for augmentation of labour. According to the dissertation, however, there was substantial overuse and misuse of oxytocin.

“Women whose labour progress was normal also received augmentation with oxytocin to speed up the progress, a treatment that can stimulate excessively frequent uterine contractions, which in turn can cause fetal distress,” Selin points out.

However, when guidelines and controls are carefully followed, i.e. both the woman’s contractions and the baby’s heart sounds are continuously monitored during administration of oxytocin, no adverse effects on the mother and child has been seen.

The fact remains that unnecessary treatment can limit the woman’s ability to move freely and in particular diminish her confidence in her own ability to give birth, Selin maintains. Selin has worked as a midwife in obstetric care for 27 years and has conducted research on delayed labour and treatment with oxytocin for 17 years.

###

Title: Delayed labour – risk factors, use of oxytocin and outcomes; http://hdl.handle.net/2077/56333

Media Contact
Lotta Selin
[email protected]
46-073-621-7894

Original Source

https://sahlgrenska.gu.se/english/research/news-events/news-article//administering-higher-doses-of-oxytocin-does-not-reduce-the-use-of-caesarean-sections.cid1604142

Tags: GynecologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Uncovering In-Utero Diagnosis of Ciliary Dyskinesia: Two Case Studies

Uncovering In-Utero Diagnosis of Ciliary Dyskinesia: Two Case Studies

August 24, 2025
New Inhibitor Targets Glioma Progression Effectively

New Inhibitor Targets Glioma Progression Effectively

August 24, 2025

Real-World Study: Efficacy of Loxenatide Plus Insulin

August 24, 2025

Link Between hs-CRP/HDL-C Ratio and Diabetes Risk

August 24, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    121 shares
    Share 48 Tweet 30
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Biological Control Flies: Deterrents Against Adelges tsugae

Seedling Success in Oromia’s Forest Restoration Efforts

Uncovering In-Utero Diagnosis of Ciliary Dyskinesia: Two Case Studies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.